{"id":667775,"date":"2023-09-13T21:24:01","date_gmt":"2023-09-13T21:24:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=667775"},"modified":"2023-09-13T21:24:01","modified_gmt":"2023-09-13T21:24:01","slug":"coccidioidomycosis-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-scynexis-mycovia-pharmaceuticals-f2g-amplyx-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/coccidioidomycosis-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-scynexis-mycovia-pharmaceuticals-f2g-amplyx-pharmaceuticals_667775.html","title":{"rendered":"Coccidioidomycosis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies &#8211; Scynexis, Mycovia Pharmaceuticals, F2G, Amplyx Pharmaceuticals"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1694598048.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Coccidioidomycosis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Scynexis, Mycovia Pharmaceuticals, F2G, Amplyx Pharmaceuticals\" src=\"https:\/\/www.abnewswire.com\/uploads\/1694598048.jpeg\" alt=\"Coccidioidomycosis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Scynexis, Mycovia Pharmaceuticals, F2G, Amplyx Pharmaceuticals\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Coccidioidomycosis Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Coccidioidomycosis Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Coccidioidomycosis, historical and forecasted epidemiology as well as the Coccidioidomycosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\">DelveInsight has launched a new report on&nbsp;<strong>&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/coccidioidomycosis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Coccidioidomycosis &#8211; Market Insights, Epidemiology, and Market Forecast-2032<\/a>&rdquo;.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/coccidioidomycosis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Coccidioidomycosis Market Report:<\/a><\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>A study said the incidence of coccidioidomycosis increases steadily with age, with those over age 70 experiencing the highest rate at 209 cases per 100,000 population while the rate for those between 1 and 4 years of age is 7.7 per 100,000 population.<\/li>\n<li>As per the study, there were 1,222 ill non-US-resident travelers with 1,393 diagnoses recorded during the 20-year analysis period. The median age was 40 (range 0&ndash;86 years); 52% were female. Patients were visited from 63 countries and territories, most commonly Canada (31%), Germany (14%), France (9%), and Japan (7%).&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Coccidioidomycosis market report covers a descriptive overview and comprehensive insight of the Coccidioidomycosis Epidemiology and Coccidioidomycosis&nbsp; market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Coccidioidomycosis market report provides insights on the current and emerging therapies.<\/li>\n<li>Coccidioidomycosis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Coccidioidomycosis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Coccidioidomycosis market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Coccidioidomycosis Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Coccidioidomycosis (also known as Valley Fever) is an infection usually caused by inhaling the spores (&ldquo;seeds&rdquo;) of either Coccidioides immitis or Coccidioides posadasii fungi. These spores are found in the soil in certain geographic areas (called endemic) and get into the air when the soil is disturbed. Coccidioidomycosis cannot be passed from person-to-person.<\/p>\n<p style=\"text-align: justify;\">There are three forms of Coccidioidomycosis i.e. acute pulmonary coccidioidomycosis, chronic pulmonary coccidioidomycosis, and disseminated coccidioidomycosis. Disseminated coccidioidomycosis, is the most severe form of the disease and occurs in about 1% of all cases, usually in people who have a poor immune system or pregnant women. This form can spread to the nervous system, bones, joints, or skin.&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Coccidioidomycosis Market&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/coccidioidomycosis-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\"><strong>Coccidioidomycosis market<\/strong>&nbsp;<\/a>are anticipated to change in the coming years owing to the expected launch of emerging therapies by companies such as <strong>Scynexis, Mycovia Pharmaceuticals, F2G, Amplyx Pharmaceuticals<\/strong>, and others during the study period 2019-2032.<\/p>\n<p style=\"text-align: justify;\"><strong>Learn more by requesting for sample&nbsp;@ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/coccidioidomycosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Coccidioidomycosis Market Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Coccidioidomycosis Pipeline Therapies and Key Companies&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Ibrexafungerp: Scynexis<\/li>\n<li>VT-1598: Mycovia Pharmaceuticals<\/li>\n<li>Fosmanogepix: Amplyx Pharmaceuticals<\/li>\n<li>Olorofim: F2G<\/li>\n<li>And others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Coccidioidomycosis Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Coccidioidomycosis Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Coccidioidomycosis Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Coccidioidomycosis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Coccidioidomycosis&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Coccidioidomycosis Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Coccidioidomycosis Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Coccidioidomycosis Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Coccidioidomycosis Market Analysis (20198&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Coccidioidomycosis Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Click here to read more about&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/coccidioidomycosis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Coccidioidomycosis Market Outlook 2032<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Coccidioidomycosis Pipeline&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Coccidioidomycosis Epidemiology&nbsp;<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=coccidioidomycosis-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-scynexis-mycovia-pharmaceuticals-f2g-amplyx-pharmaceuticals\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +91-9650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=coccidioidomycosis-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-scynexis-mycovia-pharmaceuticals-f2g-amplyx-pharmaceuticals\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Coccidioidomycosis Market DelveInsight&#8217;s &#8220;Coccidioidomycosis Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Coccidioidomycosis, historical and forecasted epidemiology as well as the Coccidioidomycosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/coccidioidomycosis-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-scynexis-mycovia-pharmaceuticals-f2g-amplyx-pharmaceuticals_667775.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-667775","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/667775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=667775"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/667775\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=667775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=667775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=667775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}